Tazemetostat hydrobromide

From WikiMD.org
Jump to navigation Jump to search
Tazemetostat hydrobromide
TermTazemetostat hydrobromide
Short definitionTazemetostat hydrobromide - (pronounced) (TA-zeh-MEH-toh-stat HY-droh-BROH-mide) drug used to treat adults and children 16 years and older with a rare type of soft tissue sarcoma called epitheloid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Tazemetostat hydrobromide - (pronounced) (TA-zeh-MEH-toh-stat HY-droh-BROH-mide) drug used to treat adults and children 16 years and older with a rare type of soft tissue sarcoma called epitheloid sarcoma and adults with certain types of follicular lymphoma. It is also being studied in the treatment of other types of cancer. Tazemetostat hydrobromide blocks certain enzymes involved in gene expression and cell division. Blocking these enzymes can help prevent cancer cells from growing. Tazemetostat hydrobromide is a type of histone methyltransferase inhibitor. Also called Tazverik

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski